Company Filing History:
Years Active: 2014
Title: Frederico Barros De Sousa: Innovator in Cardiovascular Therapeutics
Introduction
Frederico Barros De Sousa is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating cardiovascular diseases. His innovative work has led to the filing of a patent that addresses critical health issues.
Latest Patents
Frederico Barros De Sousa holds a patent for a "Process for the preparation of compositions of AT1 receptor antagonist and Angiotensin-(1-7)." This patent describes the preparation of compounds that include AT1 receptor antagonists and Angiotensin (1-7), such as Angiotensin-(1-7) losartanate and its analogues. The patent outlines the use of cyclodextrins and their derivatives for micro-encapsulation of these compounds, which can be utilized in controlled or sustained release devices. The compounds are intended for treating or preventing hypertension, cardiovascular diseases, and other related health conditions.
Career Highlights
Frederico Barros De Sousa is affiliated with the Universidade Federal de Minas Gerais, where he contributes to research and development in the pharmaceutical sciences. His work focuses on innovative solutions for cardiovascular health, showcasing his commitment to advancing medical treatments.
Collaborations
Frederico has collaborated with notable colleagues, including Rubén Dario Sinisterra Millán and Cynthia Fernandes Ferreira Santos. These collaborations have further enriched his research and development efforts in the field.
Conclusion
Frederico Barros De Sousa is a distinguished inventor whose work in cardiovascular therapeutics has the potential to significantly impact patient care. His innovative approaches to drug formulation and delivery systems highlight the importance of research in addressing critical health challenges.